Asian Spine J > Volume 17(1); 2023 > Article |
|
Conflict of Interest
David Essig receives consulting fees for Stryker and DePuy. Jeff Silber receives teaching fees for Stryker. For all remaining authors, no potential conflict of interest relevant to this article was reported.
Author Contributions
Study conception: Junho Song, Austin David Katz, David Essig; data analysis: Junho Song, Austin David Katz, Alan Job; manuscript writing: Junho Song, Austin David Katz, Dean Perfetti, Matthew Morris; manuscript revisions: all authors; supervision: Sohrab Virk, Jeff Silber, David Essig; administrative support: Sohrab Virk, Jeff Silber; and final approval of the manuscript: all authors.
Specific complications | Outpatient | Inpatient | Univariate p-value | OR (95% CI) | Multivariate p-value |
---|---|---|---|---|---|
Site-related complication | |||||
Superficial site infections | 7 (2.0) | 100 (1.2) | 0.202a) | ||
Deep wound infections | 3 (0.8) | 69 (0.8) | 0.763a) | ||
Organ space infections | 0 | 41 (0.5) | 0.411a) | ||
Dehiscence | 3 (0.8) | 63 (0.7) | 0.746a) | ||
Pulmonary complication | |||||
Pneumonia | 2 (0.6) | 100 (1.2) | 0.442a) | ||
Reintubations | 1 (0.3) | 58 (0.7) | 0.731a) | ||
Pulmonary embolism | 0 | 44 (0.5) | 0.421a) | ||
Prolonged ventilation | 0 | 34 (0.4) | 0.645a) | ||
Renal/urinary complication | |||||
Progressive renal insufficiency | 0 | 6 (0.1) | 1.000a) | ||
Acute renal failure | 0 | 13 (0.2) | 1.000a) | ||
Urinary tract infection | 0 | 134 (1.6) | 0.018 | 2.599 (0.356–18.943) | 0.346 |
Stroke/cerebrovascular accident | 0 | 18 (0.2) | 1.000a) | ||
Cardiovascular complication | |||||
Cardiac arrest requiring CPR | 0 | 14 (0.2) | 1.000a) | ||
Myocardial infarction | 0 | 31 (0.4) | 0.634a) | ||
Transfusion | 1 (0.3) | 377 (4.4) | <0.001 | 5.066 (0.698–36.765) | 0.109 |
DVT/thrombophlebitis | 1 (0.3) | 66 (0.8) | 0.524 | ||
Sepsis-related complications | 1 (0.3) | 73 (0.9) | 0.371a) |
Values are presented as number (%) or 95% (CI), unless otherwise stated. No complications were observed for the following variables: on ventilator >48 hours, progressive renal insufficiency, acute kidney injury, stroke/cerebrovascular accident, myocardial infarction, or sepsis. Bold values indicate significance (p<0.05).
Variable | Univariate | Multivariate | |||
---|---|---|---|---|---|
|
|
||||
Not readmitted (N=6,566) | Readmitted (N=620) | p-value | OR (95% CI) | p-value | |
Demographics | |||||
|
|||||
Age (yr) | 60.8±11.9 | 63.6±11.7 | <0.001 | 1.012 (1.003–1.021) | 0.008 |
|
|||||
African American race | 935 (15.6) | 99 (17.1) | 0.348 | ||
|
|||||
Hispanic ethnicity | 331 (5.5) | 24 (4.1) | 0.160 | ||
|
|||||
Male gender | 3,674 (56.0) | 375 (60.5) | 0.030 | 1.127 (0.940–1.351) | 0.197 |
|
|||||
Rehabilitation discharge | 1,569 (23.9) | 183 (29.5) | 0.002 | 1.026 (0.828–1.271) | 0.817 |
|
|||||
Comorbidities | |||||
|
|||||
Functionally dependent | 272 (4.2) | 43 (7.0) | 0.001 | 1.435 (0.996–2.069) | 0.053 |
|
|||||
Obese | 2,985 (45.6) | 301 (48.6) | 0.154 | 1.085 (0.902–1.306) | 0.386 |
|
|||||
Smoker | 1,688 (25.7) | 146 (23.5) | 0.238 | 1.047 (0.843–1.301) | 0.678 |
|
|||||
Dyspnea | 419 (6.4) | 51 (8.2) | 0.076 | ||
|
|||||
Diabetes mellitus | 1,263 (19.2) | 154 (24.8) | 0.001 | 1.123 (0.905–1.393) | 0.292 |
|
|||||
Chronic obstructive pulmonary disease | 417 (6.4) | 51 (8.2) | 0.071 | ||
|
|||||
Heart failure | 23 (0.4) | 4 (0.6) | 0.287a) | ||
|
|||||
Hypertension | 3,789 (57.7) | 411 (66.3) | <0.001 | 1.092 (0.891–1.339) | 0.396 |
|
|||||
Open wound infection | 42 (0.6) | 4 (0.6) | 1.000a) | ||
|
|||||
Chronic steroid use | 325 (4.9) | 47 (7.6) | 0.005 | 1.476 (1.059–2.058) | 0.022 |
|
|||||
Unexpected weight loss | 27 (0.4) | 7 (1.1) | 0.024a) | 2.444 (1.018–5.866) | 0.045 |
|
|||||
Bleeding disorder | 125 (1.9) | 19 (3.1) | 0.049 | 1.181 (0.700–1.992) | 0.534 |
|
|||||
American Society of Anesthesiologists-class ≥3 | 4,076 (62.1) | 451 (73.0) | <0.001 | 1.270 (1.026–1.572) | 0.028 |
|
|||||
Lab values | |||||
|
|||||
Elevated creatinine | 225 (3.8) | 55 (9.6) | <0.001 | 2.233 (1.607–3.102) | <0.001 |
|
|||||
Elevated white cell count | 416 (6.9) | 33 (5.7) | 0.297 | ||
|
|||||
Decreased hematocrit | 1,111 (18.2) | 134 (23.1) | 0.003 | 1.024 (0.819–1.279) | 0.838 |
|
|||||
Abnormal platelet count | 423 (7.0) | 52 (9.1) | 0.068 | ||
|
|||||
Procedural factors | |||||
|
|||||
Operative time (min) | 177±89 | 188±95 | 0.002 | 1.001 (1.000–1.002) | 0.086 |
|
|||||
Wound class ≥2 | 45 (0.7) | 5 (0.8) | 0.617a) | ||
|
|||||
Levels fused | 2.1±1.1 | 2.2±1.1 | 0.023 | 1.061 (0.987–1.140) | 0.111 |
|
|||||
Single-level fusion | 1,724 (26.3) | 129 (20.8) | 0.003 | ||
|
|||||
Two-level fusion | 3,586 (54.6) | 358 (57.7) | 0.135 | ||
|
|||||
≥Three-level fusion | 1,256 (19.1) | 133 (21.5) | 0.161 | ||
|
|||||
Surgical settingb) | 0.020 | 1.436 (0.789–2.613) | 0.236 | ||
|
|||||
Inpatient | 6,305 (91.2) | 607 (8.8) | |||
|
|||||
Outpatient | 261 (95.3) | 13 (4.7) |
Variable | Univariate | Multivariate | |||
---|---|---|---|---|---|
|
|
||||
No reoperation (N=8,577) | Reoperation (N=335) | p-value | OR (95% CI) | p-value | |
Demographics | |||||
|
|||||
Age (yr) | 61.2±11.9 | 62.0±11.1 | 0.250 | 0.989 (0.977–1.000) | 0.056 |
|
|||||
African American race | 1,210 (15.6) | 53 (17.0) | 0.485 | ||
|
|||||
Hispanic ethnicity | 438 (5.6) | 14 (4.5) | 0.397 | ||
|
|||||
Male gender | 4,832 (56.3) | 205 (61.2) | 0.079 | ||
|
|||||
Rehabilitation discharge | 2,063 (24.1) | 124 (37.0) | <0.001 | 1.092 (0.823–1.447) | 0.543 |
|
|||||
Comorbidities | |||||
|
|||||
Functionally dependent | 364 (4.3) | 24 (7.2) | 0.010 | 1.026 (0.623–1.689) | 0.920 |
|
|||||
Obese | 3,925 (45.9) | 158 (47.3) | 0.626 | 0.991 (0.769–1.277) | 0.946 |
|
|||||
Smoker | 2,150 (25.1) | 82 (24.5) | 0.807 | 0.858 (0.633–1.162) | 0.323 |
|
|||||
Dyspnea | 545 (6.4) | 30 (9.0) | 0.057 | ||
|
|||||
Diabetes mellitus | 1,682 (19.6) | 88 (26.3) | 0.003 | 1.187 (0.889–1.587) | 0.245 |
|
|||||
Chronic obstructive pulmonary disease | 559 (6.5) | 31 (9.3) | 0.048 | 1.172 (0.751–1.829) | 0.483 |
|
|||||
Heart failure | 34 (0.4) | 0 | 0.639a) | ||
|
|||||
Hypertension | 4,992 (58.2) | 214 (63.9) | 0.039 | 1.153 (0.870–1.527) | 0.322 |
|
|||||
Open wound infection | 50 (0.6) | 7 (2.1) | 0.005a) | 2.557 (1.042–6.278) | 0.040 |
|
|||||
Chronic steroid use | 431 (5.0) | 25 (7.5) | 0.047 | 1.419 (0.913–2.206) | 0.119 |
|
|||||
Unexpected weight loss | 39 (0.5) | 1 (0.3) | 1.000a) | ||
|
|||||
Bleeding disorder | 166 (1.9) | 8 (2.4) | 0.557 | ||
|
|||||
American Society of Anesthesiologists-class ≥3 | 5,377 (62.7) | 251 (75.1) | <0.001 | 1.406 (1.038–1.905) | 0.028 |
|
|||||
Lab values | |||||
|
|||||
Elevated creatinine | 310 (4.0) | 19 (6.4) | 0.039 | 1.378 (0.825–2.303) | 0.220 |
|
|||||
Elevated white cell count | 520 (6.6) | 25 (8.2) | 0.279 | ||
|
|||||
Decreased hematocrit | 1,439 (18.1) | 62 (20.6) | 0.257 | 0.869 (0.635–1.191) | 0.383 |
|
|||||
Abnormal platelet count | 556 (7.0) | 27 (8.9) | 0.222 | ||
|
|||||
Procedural factors | |||||
|
|||||
Operative time (min) | 176±87 | 195±106 | <0.001 | 1.000 (0.999–1.002) | 0.471 |
|
|||||
Wound class ≥2 | 58 (0.7) | 3 (0.9) | 0.500a) | ||
|
|||||
Levels fused | 2.1±1.1 | 2.2±1.2 | 0.269 | 1.027 (0.931–1.132) | 0.601 |
|
|||||
Single-level fusion | 2,205 (25.7) | 78 (23.3) | 0.319 | ||
|
|||||
Two-level fusion | 4,703 (54.8) | 188 (56.1) | 0.642 | ||
|
|||||
≥Three-level fusion | 1,669 (19.5) | 69 (20.6) | 0.606 | ||
|
|||||
Surgical settingb) | 0.038 | 1.317 (0.565–3.066) | 0.524 | ||
|
|||||
Inpatient | 8,230 (96.2) | 329 (3.8) | |||
|
|||||
Outpatient | 347 (98.3) | 6 (1.7) |
Variable | Univariate | Multivariate | |||
---|---|---|---|---|---|
|
|
||||
No morbidity (N=7,940) | Morbidity (N=972) | p-value | OR (95% CI) | p-value | |
Demographics | |||||
Age (yr) | 64.0±11.5 | 60.9±11.9 | <0.001 | 1.007 (0.999–1.014) | 0.077 |
African American race | 1,112 (15.4) | 151 (17.3) | 0.147 | ||
Hispanic ethnicity | 398 (5.5) | 54 (6.1) | 0.451 | ||
Male gender | 4,485 (56.5) | 552 (56.8) | 0.857 | ||
Rehabilitation discharge | 1,764 (22.2) | 423 (43.5) | <0.001 | 1.412 (1.192–1.675) | <0.001 |
Comorbidities | |||||
Functionally dependent | 308 (3.9) | 80 (8.3) | <0.001 | 1.295 (0.965–1.739) | 0.085 |
Obese | 3,620 (45.8) | 463 (47.9) | 0.214 | 1.096 (0.934–1.285) | 0.261 |
Smoker | 2,008 (25.3) | 224 (23.0) | 0.127 | 1.065 (0.880–1.288) | 0.518 |
Dyspnea | 481 (6.1) | 94 (9.7) | <0.001 | 1.282 (0.975–1.686) | 0.075 |
Diabetes mellitus | 1,519 (19.1) | 251 (25.8) | <0.001 | 1.054 (0.876–1.268) | 0.577 |
Chronic obstructive pulmonary disease | 495 (6.2) | 95 (9.8) | <0.001 | 1.192 (0.901–1.578) | 0.219 |
Heart failure | 28 (0.4) | 6 (0.6) | 0.261a) | ||
Hypertension | 4,558 (57.4) | 648 (66.7) | <0.001 | 1.051 (0.881–1.252) | 0.582 |
Open wound infection | 46 (0.6) | 11 (1.1) | 0.041 | 0.816 (0.372–1.791) | 0.613 |
Chronic steroid use | 387 (4.9) | 69 (7.1) | 0.003 | 1.124 (0.832–1.517) | 0.446 |
Unexpected weight loss | 35 (0.4) | 5 (0.5) | 0.746 | ||
Bleeding disorder | 143 (1.8) | 31 (3.2) | 0.003 | 1.164 (0.739–1.834) | 0.512 |
American Society of Anesthesiologists-class ≥3 | 4,878 (61.5) | 750 (77.2) | <0.001 | 1.296 (1.072–1.568) | 0.008 |
Lab values | |||||
Elevated creatinine | 255 (3.6) | 74 (8.3) | <0.001 | 1.625 (1.202–2.198) | 0.002 |
Elevated white cell count | 491 (6.7) | 54 (6.0) | 0.391 | ||
Decreased hematocrit | 1,219 (16.5) | 284 (31.3) | <0.001 | 1.700 (1.425–2.029) | <0.001 |
Abnormal platelet count | 490 (6.7) | 93 (10.3) | <0.001 | 1.205 (0.926–1.566) | 0.165 |
Procedural factors | |||||
Operative time (min) | 170±82 | 228±117 | <0.001 | 1.005 (1.004–1.006) | <0.001 |
Wound class ≥2 | 51 (0.6) | 10 (1.0) | 0.168 | ||
Levels fused | 2.1±1.1 | 2.3±1.4 | <0.001 | 1.028 (0.967–1.092) | 0.379 |
Single-level fusion | 2,073 (26.1) | 210 (21.6) | 0.002 | ||
Two-level fusion | 4,329 (54.5) | 562 (57.8) | 0.051 | ||
≥Three-level fusion | 1,538 (19.4) | 200 (20.6) | 0.370 | ||
Surgical settingb) | <0.001 | 1.108 (0.639–1.921) | 0.716 | ||
Inpatient | 7,603 (88.8) | 956 (11.2) | |||
Outpatient | 337 (95.5) | 16 (4.5) |